Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Willmar Schwabe India is a prominent pharmaceutical company specializing in the manufacture and distribution of homeopathic and phytotherapeutic medicines. Established in 1994 as a subsidiary of the German-based Schwabe Group, the company operates a high-tech manufacturing facility in Noida that complies with international Good Manufacturing Practice (GMP) standards. Their extensive product portfolio includes mother tinctures, dilutions, biochemic tablets, and specialized formulations such as the Alpha and Pentarkan ranges. The company is dedicated to providing standardized, high-quality natural medicines by integrating traditional knowledge with modern scientific validation and rigorous quality control. Schwabe India plays a significant role in the Indian healthcare sector by making globally recognized homeopathic treatments accessible to a wide network of practitioners and patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Willmar Schwabe India.